MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Description
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund.
Investor Profile
MRL Ventures Fund has made 47 investments, with 4 in the past 12 months and 15% as lead.
Stage Focus
- Series A (40%)
- Series B (23%)
- Series C (21%)
- Seed (6%)
- Series E (2%)
- Series D (2%)
- Series Unknown (2%)
- Corporate Round (2%)
Country Focus
- United States (91%)
- The Netherlands (6%)
- Belgium (2%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Medical
- Life Science
- Genetics
- Oncology
- Medical Device
- Biopharma
- Emergency Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
